Perennial second private to public fund fully subscribed
Perennial’s Private to Public Opportunities fund No.2 fund (PPP2) has closed its capital raising fully subscribed, raising $125 million.
The launch of the fund by Perennial followed the success of its first private companies fund (PPP), and the new strategy which announced in September, would employ the same investment strategy as its predecessor fund with the aim to generate superior returns over a five-year period.
According to FE Analytics, the first Private to Public Opportunity fund had returned 31.89% since inception on 16 August, 2019, to 31 August, 2020.
The fund aimed to invest in high-growth equity opportunities through an actively managed portfolio of 30-45 unlisted, pre-IPO and listed Australian companies.
Perennial said it had already identified several private and pre-IPO investments for the new fund, with the deployment of capital to commence immediately.
Andrew Smith, Perennial head of smaller companies and microcaps, said: “We appreciate the support from investors for our initial PPP fund, as well as the strong demand experienced for PPP2. We are very pleased to reach the maximum fund target size of $125 million for our second PPP fund”.
Brendan Lyons, Perennial head of private investments, said investors had been supportive of the fund’s investment strategy, which focused on the Last Private Offer (LPO) undertaken by founder-led companies prior to an IPO or other liquidity event.
“Our systematic process, coupled with a large and growing pipeline of private opportunities, provides a diversified investment exposure which is otherwise difficult to access,” Lyons said.
“In addition, increased volatility in global equity markets this year has prompted many investors to seek out alternate sources of return.”
Ryan Sohn, deputy portfolio manager, said two of the initial investments included e-commerce businesses with significant scale as well as a health technology company with unique intellectual property.
“We have followed the growth of these businesses for a significant period of time and are delighted to now be part of the journey with them,” Sohn said.
Some of the businesses the first fund invested in included soft tissue regeneration business Aroa Biosurgery, diagnostic testing business Atomo Diagnostics and lung imaging technology firm 4D Medical, which all became listed on the Australian Securities Exchange (ASX) this year.
Performance of the Perennial Private to Public Opportunity fund since inception to 31 August 2020
AUTHOR
Chris Dastoor
Recommended for you
Selfwealth has provided an update on the status of its scheme implementation deed with Bell Financial Group as well as whether rival bidder Svava remains in the picture.
Magellan Financial Group has reported its first half FY25 results while appointing a new chief financial officer and promoting Sophia Rahmani to chief executive.
Schroders Australia has launched two active ETFs and plans to further expand its listed range over the year ahead.
Platform Netwealth has reported its financial results for the first half of FY25, reporting an 80 per cent increase in net flows, with its CEO viewing a “huge opportunity” from private assets.
